Compare · CELZ vs MCO
CELZ vs MCO
Side-by-side comparison of Creative Medical Technology Holdings Inc. (CELZ) and Moody's Corporation (MCO): market cap, price performance, sector, and recent activity on the wire.
Summary
- CELZ operates in Health Care, while MCO operates in Finance - the two are in different parts of the market.
- MCO is the larger of the two at $87.28B, about 21894.5x CELZ ($4.0M).
- MCO has been more active in the news (14 items in the past 4 weeks vs 3 for CELZ).
- MCO has more recent analyst coverage (25 ratings vs 1 for CELZ).
- Company
- Creative Medical Technology Holdings Inc.
- Moody's Corporation
- Price
- -
- -
- Market cap
- $4.0M
- $87.28B
- 1M return
- -
- +4.41%
- 1Y return
- -
- +7.23%
- Industry
- Biotechnology: Biological Products (No Diagnostic Substances)
- Finance: Consumer Services
- Exchange
- NASDAQ
- NYSE
- IPO
- News (4w)
- 3
- 14
- Recent ratings
- 1
- 25
Creative Medical Technology Holdings Inc.
Creative Medical Technology Holdings, Inc., a biotechnology company, focuses on immunology, urology, orthopedics, and neurology using adult stem cell treatments. The company offers CaverStem for the treatment of erectile dysfunction; FemCelz for the treatment of loss of genital sensitivity and dryness; StemSpine for the treatment of chronic lower back pain; Amniostem for the treatment of strokes, radiation, toxicity, and glioma; ImmCelz for the treatment of stroke patients; and OvaStem for treatment of female infertility. Creative Medical Technology Holdings, Inc. was incorporated in 1998 and is based in Phoenix, Arizona.
Moody's Corporation
Moody's Corporation operates as an integrated risk assessment firm worldwide. It operates in two segments, Moody's Investors Service and Moody's Analytics. The Moody's Investors Service segment publishes credit ratings and provides assessment services on various debt obligations, programs and facilities, and entities that issue such obligations, such as various corporate, financial institution, and governmental obligations; and structured finance securities. This segment provides ratings in approximately 140 countries. Its ratings are disseminated through press releases to the public through electronic media, including the internet and real-time information systems used by securities traders and investors. This segment has rated approximately 5,000 non-financial corporates; 3,600 financial institutions; 16,000 public finance issuers; 145 sovereigns; 47 supranational institutions; 459 sub-sovereigns; and 1,000 infrastructure and project finance issuers, as well as 9,100 structured finance deals. The Moody's Analytics segment develops a range of products and services that support the risk management activities of institutional participants in financial markets; and offers subscription based research, data, and analytical products comprising credit ratings, credit research, quantitative credit scores and other analytical tools, economic research and forecasts, business intelligence and company information products, commercial real estate data and analytical tools, and on-line and classroom-based training services, as well as credentialing and certification services. It also offers software solutions, as well as related risk management services; and offshore analytical and research services with learning solutions and certification programs. The company was formerly known as Dun and Bradstreet Company and changed its name to Moody's Corporation in September 2000. Moody's Corporation was founded in 1900 and is headquartered in New York, New York.
Latest CELZ
- Creative Medical Technology Holdings Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and Exhibits
- SEC Form DEF 14A filed by Creative Medical Technology Holdings Inc.
- SEC Form 10-Q filed by Creative Medical Technology Holdings Inc.
- Creative Medical Technology Holdings Highlights 93% Patient Response Rate and 65% Reduction in Average Pain Scores in Ultrasome™ Knee Osteoarthritis Study
- President & CEO Warbington Timothy was granted 1,000,000 shares (SEC Form 4)
- Creative Medical Technology Holdings Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits
- Creative Medical Technology Holdings, Inc. Expands Ultrasome™ Intellectual Property Portfolio with New U.S. Provisional Patent Filing
- Creative Medical Technology Holdings Inc. filed SEC Form 8-K: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits
- Creative Medical Technology Holdings Successfully Completes Enrollment and Treatment Across Entire FDA-Cleared ADAPT Trial, Including Opioid Cohort, Advancing CELZ-201 / Olastrocel Toward RMAT Evaluation and Phase 3 Planning
- SEC Form 10-Q filed by Creative Medical Technology Holdings Inc.
Latest MCO
- Moody’s Names Timothy Bhatt as Chief Information Officer
- Moody's Corporation filed SEC Form 8-K: Other Events, Financial Statements and Exhibits
- President and CEO Fauber Robert exercised 1,743 shares at a strike of $199.31 and sold $890,237 worth of shares (1,743 units at $510.75) as part of a pre-agreed trading plan (SEC Form 4)
- Moody’s Corporation to Present at the J.P. Morgan Ultimate Services Investor Conference on November 17, 2026
- SEC Form FWP filed by Moody's Corporation
- SEC Form 305B2 filed by Moody's Corporation
- SEC Form 424B5 filed by Moody's Corporation
- Chief Acctg Off & Controller Phillips Jason D sold $49,336 worth of shares (95 units at $519.33), decreasing direct ownership by 5% to 1,799 units (SEC Form 4)
- CEO - Moody's Ratings West Michael L sold $103,200 worth of shares (195 units at $529.23), decreasing direct ownership by 2% to 8,179 units (SEC Form 4)
- CEO - Moody's Ratings West Michael L sold $93,774 worth of shares (185 units at $506.88), decreasing direct ownership by 2% to 8,374 units (SEC Form 4)